Kyle Young, PA-C | |
5301 S Congress Ave, Suite 300, Atlantis, FL 33462-1149 | |
(561) 548-4900 | |
(561) 548-4902 |
Full Name | Kyle Young |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 21 Years |
Location | 5301 S Congress Ave, Atlantis, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376522136 | NPI | - | NPPES |
GB931Z | Other | FL | MEDICARE ID |
41987300 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AS0400X | Physician Assistant - Surgical | 1612-023 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jfk Medical Center | Atlantis, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lawnwood Cardiovascular Surgery Llc | 7214937598 | 54 |
News Archive
While people of color have a lower risk of developing skin cancer than Caucasians, they are not immune to the disease. In fact, skin cancer is often diagnosed at a more advanced stage in people of color, which can make it more difficult to treat.
Stallergenes S.A. today announced the first results of a phase III clinical trial (VO61.08) conducted in the USA on its sublingual grass pollen immunotherapy tablet, Oralair(R).
The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
INTEGRA has published a video demonstrating how its VIAFLO 96 handheld electronic pipette, used in conjunction with the Seahorse Bioscience XF96 Extracellular Flux Analyzer, provides high throughput screening of the cellular bioenergetics of multiple cell lines.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Kyle Young, PA-C 5301 S Congress Ave, Suite 300, Atlantis, FL 33462-1149 Ph: (561) 548-4900 | Kyle Young, PA-C 5301 S Congress Ave, Suite 300, Atlantis, FL 33462-1149 Ph: (561) 548-4900 |
News Archive
While people of color have a lower risk of developing skin cancer than Caucasians, they are not immune to the disease. In fact, skin cancer is often diagnosed at a more advanced stage in people of color, which can make it more difficult to treat.
Stallergenes S.A. today announced the first results of a phase III clinical trial (VO61.08) conducted in the USA on its sublingual grass pollen immunotherapy tablet, Oralair(R).
The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
INTEGRA has published a video demonstrating how its VIAFLO 96 handheld electronic pipette, used in conjunction with the Seahorse Bioscience XF96 Extracellular Flux Analyzer, provides high throughput screening of the cellular bioenergetics of multiple cell lines.
› Verified 8 days ago
Michelle Barletta, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Rothman Center 4th Floor, Atlantis, FL 33462 Phone: 561-548-8600 Fax: 561-548-8650 | |
Ms. Debra L. Baldwin, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 180 Jfk Dr Ste 320, Atlantis, FL 33462 Phone: 561-548-4900 Fax: 561-434-5165 | |
Ms. Camille J Dyer, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave Ste 102, Atlantis, FL 33462 Phone: 561-967-5033 Fax: 561-967-5424 | |
Mr. Aleksandr V Potashnik, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Bldg. #300, Atlantis, FL 33462 Phone: 561-548-4900 Fax: 561-548-4902 | |
Nestor G Via Y Rada, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 180 Jfk Dr Ste 320, Atlantis, FL 33462 Phone: 561-548-4900 Fax: 561-434-5165 | |
Mrs. Sheree Waterous, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 205 Jfk Dr, Suite A, Atlantis, FL 33462 Phone: 561-432-8935 Fax: 561-432-8937 | |
James Swann, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5301 S Congress Ave, Bldg. 300, Atlantis, FL 33462 Phone: 561-548-4900 Fax: 561-548-4902 |